Evidence map›Paper›PMID 32282949›Full record

SynthesisAmerican journal of hematology2020

Hematological findings and complications of COVID-19.

Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Ismail Elalamy, Efstathios Kastritis, Theodoros N Sergentanis, Marianna Politou, Theodora Psaltopoulou, Grigoris Gerotziafas, Meletios A Dimopoulos

2 registry-linked trialsOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in American journal of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 962 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
962citing papers in PubMed, 1 pooled it
39.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04982263 completednot on this mapstarted 2021, after this paper: background citation

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

TypeobservationalSponsorSohag UniversityRan2021 to 2021Enrolled125ConditionsCovid19ArmsBlood coagulation profile
NCT05299346 completednot on this map

Post-ICU Covid19 Follow-up With Regards to Lung, Heart, Kidney and Cognitive Function

Typeobservational_patient_registrySponsorSahlgrenska University HospitalRan2020 to 2023Enrolled793ConditionsCOVID-19 Pandemic, Intensive Care Unit Syndrome, DeliriumArmsFollow up
3 · Its place in the literature

Who cites it

962 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,724 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Lung Abscess in a COVID-19 Patient: A Case Report.Advanced biomedical research · 2026
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Characteristics of the gut-lung axis in patients with viral pneumonia and respiratory failure.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  16. Article
  17. COVID-19 Infection, Drugs, and Liver Injury.Journal of clinical medicine · 2025
    Review
  18. Article
  19. Review
  20. Article

902 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Evangelos TerposDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0001-5133-1422
Ioannis Ntanasis-StathopoulosDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0002-6328-9783
Ismail ElalamyHematology and Thrombosis Center, Tenon University Hospital, Sorbonne University, INSERM U938, Sorbonne University, Paris, France.
Efstathios KastritisDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0001-8191-5832
Theodoros N SergentanisDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Marianna PolitouHematology Laboratory-Blood Bank, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Theodora PsaltopoulouDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Grigoris GerotziafasHematology and Thrombosis Center, Tenon University Hospital, Sorbonne University, INSERM U938, Sorbonne University, Paris, France.
Meletios A DimopoulosDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0001-8990-3254
National and Kapodistrian University of Athens · GRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and peak platelet/lymphocyte ratio may also have prognostic value in determining severe cases. During the disease course, longitudinal evaluation of lymphocyte count dynamics and inflammatory indices, including LDH, CRP and IL-6 may help to identify cases with dismal prognosis and prompt intervention in order to improve outcomes. Biomarkers, such high serum procalcitonin and ferritin have also emerged as poor prognostic factors. Furthermore, blood hypercoagulability is common among hospitalized COVID-19 patients. Elevated D-Dimer levels are consistently reported, whereas their gradual increase during disease course is particularly associated with disease worsening. Other coagulation abnormalities such as PT and aPTT prolongation, fibrin degradation products increase, with severe thrombocytopenia lead to life-threatening disseminated intravascular coagulation (DIC), which necessitates continuous vigilance and prompt intervention. So, COVID-19 infected patients, whether hospitalized or ambulatory, are at high risk for venous thromboembolism, and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended. Last but not least, the need for assuring blood donations during the pandemic is also highlighted.

Indexed as

BetacoronavirusAnticoagulantsBiomarkersBlood Coagulation TestsBlood DonorsClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingC-Reactive ProteinCytokine Release SyndromeCytokinesDisseminated Intravascular CoagulationEarly DiagnosisFerritinsFibrin Fibrinogen Degradation ProductsAnticoagulantsBiomarkersC-Reactive ProteinCytokinesFerritinsFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID32282949
PMCPMC7262337
OpenAlexW3016126001

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.